|
|
Expedited Review for Post-marketing Minimal Risk ResearchQuorum Review recognizes the growing importance of post-marketing research and other studies that gather drug and safety information while posing minimal risk to participants. To support this type of research, Quorum now offers Qualified Minimal Risk (QMR) review. QMR is a submission process tailored to fit the nature of minimal risk research and bolstered by Quorum's established rapid study start-up infrastructure. Under QMR, site submissions are reviewed within two working days and documents are shipped out within two days of an approval. Quorum's approach to QMR research: Quorum provides the following services for QMR research:
In addition, Quorum's standard suite of support services - a Study Manager as a single point of contact, the Customer Relations and Site Support teams, in-house translations, secure web portal etc. - combine with QMR to deliver world class performance. Which studies qualify? QMR utilizes Quorum's established expedited review process. Federal regulations allow an IRB to review new research proposals by expedited review when that research passes a two-pronged test: At the sponsor's request, Quorum's Expedited Reviewers will establish a study's status as QMR during initial review of a protocol submission. Quorum's Customer Relations team can assist with the initial QMR submission process and answer any other questions. Quorum's phone number is (206) 448-4082. |